DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Von Minckwitz G, Procter M, De Azambuja E. et al.
Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer.
N Engl J Med 2017;
377: 122-131
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.